What breast cancer medicine will India and Brazil jointly develop?

India and Brazil will jointly develop Pertuzumab, a medicine indicated for HER-2 metastatic breast cancer.

What are the key areas of cooperation between India and Brazil?

Key areas include the development of breast cancer medicine, cooperation in iron ore blending, R&D in strategic pharmaceutical ingredients, and boosting trade and investment.

What is the estimated value of the iron ore blending facility project?

The iron ore blending facility project at Gangavaram Port is valued at approximately USD 500 million.

Home / Business and Economy / India, Brazil Forge Pharma & Trade Pacts

India, Brazil Forge Pharma & Trade Pacts

22 Feb

•

Summary

India and Brazil signed agreements on breast cancer medicine and iron ore blending.
Research and development in strategic pharmaceutical ingredients will be enhanced.
Trade and investment between India and Brazil are set to increase.

India, Brazil Forge Pharma & Trade Pacts

India and Brazil have solidified bilateral ties with several Memoranda of Understanding (MoUs) signed during Brazilian President Luiz Inacio Lula da Silva's recent visit. These agreements mark a significant step forward in cooperation across key sectors.

A crucial pact involves the joint development of Pertuzumab, a medicine indicated for HER-2 metastatic breast cancer. This collaboration was formalized between BahiaFarma, Biocon Biologics Ltd, and Bionovis.